Junaid Kamal, MD
Anesthesiology · Houston, TXNPI 1760598619
Payments from drug & device makers
Across 80 payments — averaging $33.55 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.
- Medtronic$2K
- AbbVie$168
- Novo Nordisk$148
- Amgen$142
- Amarin Pharma, Inc.$90
- Boehringer Ingelheim$70
- plus $531 from 19 others
What the payments were for
- Travel & lodging$72627%
- Food & beverage$1,95873%
Most of this is food and beverage — typically meals provided during product presentations at a clinic or hospital. Nationally that is the single largest category of reported payments by count.
General payments by program year
Who reported the general payments
Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.
| Company | Payments | Total |
|---|---|---|
| Medtronic(2 entities) | 21 | $1,535 |
| AbbVie(2 entities) | 9 | $168 |
| Novo Nordisk | 8 | $148 |
| Amgen | 7 | $142 |
| Amarin Pharma, Inc. | 4 | $90 |
| Boehringer Ingelheim | 4 | $70 |
| Nevro Corp. | 2 | $68 |
| Biohaven Pharmaceuticals, Inc. | 2 | $61 |
| Abbott | 3 | $59 |
| Bayer | 2 | $39 |
| Lilly USA, LLC | 2 | $34 |
| Dexcom, Inc. | 1 | $34 |
| Johnson & Johnson(2 entities) | 2 | $30 |
| Stimwave Technologies Incorporated | 2 | $27 |
| Salix Pharmaceuticals, A Division Of Bausch Health US, LLC | 1 | $25 |
| Amniox Medical, Inc. | 1 | $23 |
| Nalu Medical, Inc. | 1 | $19 |
| Mauna Kea Technologies, Inc. | 1 | $17 |
| Fidia Pharma USA Inc. | 1 | $16 |
| AstraZeneca | 1 | $16 |
| Boston Scientific | 1 | $15 |
| Ardelyx, Inc. | 1 | $14 |
| Kowa Pharmaceuticals America, Inc. | 1 | $13 |
| Circassia Inc. | 1 | $12 |
| GSK | 1 | $11 |
What the payments were tied to
Products named in the reported payments. Only payments of $100 or more are attributed here — the typical reported payment nationally is a meal worth about $16, and listing those product-by-product would be noise.
How this compares
$2,684 in reported general payments places this provider in the 90th percentile of 3,899 anesthesiology providers in Texas.
Medicare billing
What this is not: this is the amount Original Medicare Part B allowed for services this provider billed in 2024. It is not their income. It excludes Medicare Advantage — now more than half of all Medicare enrollment — along with Medicaid and all commercial insurance, and it is gross practice revenue before staff, rent, supplies and malpractice premiums. CMS also suppresses any figure covering ten or fewer patients, so low-volume providers appear smaller than they are.
Most prescribed under Part D
| Drug | Claims | Cost to plans & patients |
|---|---|---|
| Hydrocodone-AcetaminophenHydrocodone/Acetaminophen | 174 | $3,725 |
| Pregabalin | 110 | $2,643 |
| Gabapentin | 66 | $1,141 |
| Tramadol Hcl | 181 | $994 |
| Oxycodone-AcetaminophenOxycodone Hcl/Acetaminophen | 35 | $757 |
| Acetaminophen-CodeineAcetaminophen With Codeine | 66 | $541 |
| Fentanyl | 13 | $452 |
| Celecoxib | 20 | $435 |
| Methocarbamol | 28 | $422 |
| Baclofen | 40 | $273 |
| Tizanidine Hcl | 19 | $221 |
| Amitriptyline Hcl | 20 | $81 |
| Cyclobenzaprine Hcl | 13 | $42 |
| Ibuprofen | 14 | $34 |
| Clonidine Hcl | 18 | $32 |
Paid to pharmacies, not to this prescriber.
Other anesthesiology in Houston
- David BrownHouston$2.5M
- Holger EltzschigHouston$1.6M
- Maria MatuszczakHouston$907K
- Tong GanHouston$703K
- Gabriel MenaHouston$494K
- Juan CataHouston$387K
- Harold MinkowitzHouston$241K
- Eric ChanHouston$128K
- John ZakiHouston$109K
- Farzin GoravanchiHouston$88K
Where these figures come from
- Payments: CMS Open Payments, program years 2019–2025 (publication P06302026_06032026).
- Billing: Medicare Physician & Other Practitioners, data year 2024. Original Medicare Part B only.
- Identity: NPPES NPI Registry, July 2026.